VerifiedBiotechnology Research· Founded 2021

Pangea Bio

Pangea Bio is developing novel therapies that directly activate the TrkB receptor, driving neuronal and synaptic plasticity, and neuroprotection. Dysfunction of the BDNF/TrkB pathway is a hallmark of disorders such as schizophrenia, depression, Alzheimer’s disease, Parkinson’s disease, and glaucoma.

7-day free trial · no credit card

London, United Kingdom31(11 to 50)2021pangeabio.com LinkedIn

Verified contacts

25

available on Kipplo

LinkedIn employees

31

11 to 50 range

Open roles

—

no listings

Distinct roles

20

indexed titles

Tech stack

0

tools in use

Monthly traffic

28

organic / mo

Sign up free to see all 25 verified contacts at Pangea Bio

Free for 7 days · 50 credits · no card · only pay for verified records.

Decision-makers and verified team members

25 contacts with verified email or phone · masked until revealed.

Sign up free →

Showing 9 of 25 verified contacts

Top roles at Pangea Bio

20 distinct titles indexed · top 10 shown.

2senior director of intellectual property
1- &
1- - ä
1-,,
1associate director, nonclinical development
1business development and operations
1ceo, chairman & co-founder
1chief financial officer
1chief scientific officer
1cmc lead
+10more titles

Sign up to unlock all 25 contacts at Pangea Bio

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up to reveal 25 verified contacts at Pangea Bio

7-day trial · no credit card · cancel anytime · only pay for verified records.

Sign up free See pricing

Trusted by sales, marketing, and GTM engineering teams.

Pangea Bio | Kipplo Discover